The Technical University of Munich is a public research university in Munich, with additional campuses in Garching, Freising, Heilbronn, Straubing, and Singapore.

During the past decade, Technical University Munich, German Heart Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Technical University Munich, German Heart Center" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Diabetes" (1 trials), "Symptomatic Atherosclerosis" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Technical University Munich, German Heart Center" in a lesser frequency.

Most popular intervention types in "Technical University Munich, German Heart Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALN-PCSSC" (1 trials), "Evolocumab" (1 trials), "Inclisiran" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Technical University Munich, German Heart Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Technical University Munich, German Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Technical University Munich, German Heart Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Technical University Munich, German Heart Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".